In vitro enhancement of human platelet aggregation by somatostatin
- 1 October 1988
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 44 (10) , 892-894
- https://doi.org/10.1007/bf01941192
Abstract
Very low concentrations of somatostatin (S-14) strongly potentiate the in vitro aggregation induced by collagen, ristocetin and arachidonic acid, but not that induced by ADP or epinephrine, in both human platelet rich plasmas and gel-filtered platelet preparations. Desensitization phenomena may be induced either by repeated addition of S-14 or long lasting contact between S-14 and platelets.This publication has 25 references indexed in Scilit:
- Human platelet fraction arginine-vasopressin. Potential physiological role.Journal of Clinical Investigation, 1987
- Somatostatin in the treatment of severe upper gastrointestinal bleeding: A multicentre controlled trialBritish Journal of Surgery, 1986
- Somatostatin ReceptorsScandinavian Journal of Gastroenterology, 1986
- Different effects of three kinds of somatostatin (15–28, 1–14, 1–28) on rabbit's platelet aggregationLife Sciences, 1985
- Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage.Gut, 1985
- SOMATOSTATIN IN TREATMENT OF HAEMATEMESIS AND MELAENAThe Lancet, 1985
- Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract.BMJ, 1984
- SOMATOSTATIN AND CIMETIDINE IN PEPTIC-ULCER HÆMORRHAGEThe Lancet, 1980
- SOMATOSTATIN IN ACUTE GASTRODUODENAL HqMORRHAGEThe Lancet, 1978
- IMPAIRMENT OF PLATELET FUNCTION BY GROWTH-HORMONE RELEASE- INHIBITING HORMONEThe Lancet, 1975